您当前的位置:
首页 >
文章列表页 >
Research Progress and Evaluation of Active Targeting Drug Delivery for Lung Cancer
更新时间:2024-01-04
    • Research Progress and Evaluation of Active Targeting Drug Delivery for Lung Cancer

    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 19, Issue 12, Pages: 360-366(2013)
    • DOI:10.11653/syfj2013120360    

      CLC:
    • Published:2013

    移动端阅览

  • CHEN Yan-gang, ZHU Hong. Research Progress and Evaluation of Active Targeting Drug Delivery for Lung Cancer[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(12): 360-366. DOI: 10.11653/syfj2013120360.

  •  
  •  

0

Views

4

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Research Progress of Lung Cancer Related to Endogenous Hormone and its Receptor
Effect of Wenyang Sanjie Prescription on Tumor Inhibition and STAT3/HIF-1α Pathway in Lung Cancer Tumor-bearing Mice
Invasion and Metastasis Inhibition of Lung Cancer by Traditional Chinese Medicine: A Review
Mechanism of Traditional Chinese Medicine Regulating JAK/STAT Signaling Pathway to Intervene in Lung Cancer: A Review
Effect of Guiqi Yiyuan Ointment on Lewis Lung Cancer Mice by Increasing Autophagic Flux and Stabilizing PD-L1 Expression Through Regulation of ERK Signaling Pathway

Related Author

ZHANG Zheng-bing
ZHANG Hai-tao
DU Kan
ZANG Lin-quan
WANG Xinxin
GUO Junhui
LI Honglin
ZHENG Fengyu

Related Institution

Henan Province Hospital of Traditional Chinese Medicine
The Second Clinical Medical College, Henan University of Chinese Medicine
The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital
Henan Province Hospital of Traditional Chinese Medicine/The Second Affiliated Hospital of Henan University of Chinese Medicine
School of Basic Medicine, Gansu University of Chinese Medicine
0